• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Enforcement Report - Week of July 24, 2013

  • Print
  • Share
  • E-mail
-

Product Detail

Product Description Source Plasma
Recall Number B-1629-13
Classification Class II
Code Info 4270183014, 4270181851, 4270180003, 4270174788, 4270173161, 4270171887, 4270165471, 4270162492, 4270161125, 4270160357, 4270159126, 4270157892, 4270157329, 4270155736, 4270155211, 4270153782, 4270153425, 4270152091, 4270151567, 4270150167, 4270148507, 4270147032, 4270146491, 4270145367, 4270144221, 4270143653, 4270141052, 4270139728, 4270139214, 4270138216, 4270137713, 4270136676, 4270136156, 4270134929, 4270134542, 4270131147, 4270129852
Product Distributed Qty 37 units
Reason For Recall Blood products, collected from a donor who did not have a complete physical examination, were distributed.

Event Detail

Event Id 50444
Product Type Biologics
Status Terminated
Recalling Firm Csl Plasma Inc
City Tempe
State AZ
Country US
Voluntary / Mandated Voluntary: Firm Initiated
Recall Initiation Date 2008-10-07
Initial Firm Notification of Consignee or Public Letter
Distribution Pattern Illinois, Switzerland, Germany
-
-